The Atlanta Braves just made a bold move that could shape their future—locking in veteran pitcher Chris Sale through 2028. But here’s where it gets controversial: is this a smart investment in a proven ace, or a risky bet on a player nearing the twilight of his career? Let’s dive in.
On February 24, the Braves announced a contract extension for Chris Sale, ensuring the left-handed pitcher remains in Atlanta for the foreseeable future. The deal includes a lucrative option for 2028, valued at a staggering $30 million, if the team decides to exercise it. This comes after the Braves activated an $18 million team option at the end of the 2025 season to keep Sale on board for 2026, just as his previous contract was set to expire.
Sale, who turns 37 on March 30—coincidentally, the opening game of Atlanta’s second series in the 2026 season—has been a cornerstone of the Braves’ rotation. Despite battling a fractured ribcage that sidelined him for 10 weeks in 2025, he posted a solid 7-5 record with a 2.58 ERA. His resilience was on full display in September, when he returned to the rotation and delivered four nine-strikeout games in just five starts, finishing the season with 165 strikeouts.
And this is the part most people miss: Sale’s 2024 debut season in Atlanta and the National League was nothing short of spectacular. He led the NL with 18 wins, a 2.38 ERA, and 225 strikeouts, proving he still has elite-level stuff. But with age comes questions about durability—can he maintain this level of performance as he approaches his late 30s?
Before joining the Braves, Sale spent 13 seasons in the American League, starting with the Chicago White Sox in 2010 and later moving to the Boston Red Sox in 2017. Over his career, he’s amassed a 145-88 record in 393 games (312 starts), with a 3.01 ERA and a whopping 2,579 strikeouts in 2,084 innings. These numbers speak to his consistency and dominance, but they also highlight the wear and tear of a long career.
The Braves’ decision to extend Sale is a double-edged sword. On one hand, it secures a seasoned pitcher who can mentor younger talent and provide stability in the rotation. On the other hand, it’s a significant financial commitment to a player whose injury history and age could become liabilities. Is this a masterstroke or a gamble? Weigh in below—do you think the Braves made the right call, or are they setting themselves up for potential disappointment?
One thing’s for sure: Chris Sale’s journey in Atlanta is far from over, and baseball fans will be watching closely to see how this story unfolds. Will he continue to defy the odds, or will Father Time catch up? Only time will tell.
